Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

APO-ERLOTINIB is prescribed for non-small cell lung cancer at an advanced stage and; chemotherapy has not helped to stop the disease or; the disease has not worsened after 4 cycles of first line chemotherapy; or a confirmed activating mutation of the Epidermal Growth Factor Receptor tyrosine kinase (EGFR-TK).
APO-ERLOTINIB is not indicated for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours DO NOT HAVE an epidermal growth factor receptor (EGFR) activating mutation.

Apo-Erlotinib Indications/Uses

erlotinib

Manufacturer:

Apotex

Distributor:

Hind Wing